|
1
|
Behin A, Hoang-Xuan K, Carpentier AF and
Delattre J-Y: Primary brain tumours in adults. Lancet. 361:323–331.
2003.
|
|
2
|
Lacroix M, Abi-Said D, Fourney DR, et al:
A multivariate analysis of 416 patients with glioblastoma
multiforme: prognosis, extent of resection, and survival. J
Neurosurg. 95:190–198. 2001.
|
|
3
|
Stewart L: Chemotherapy in adult
high-grade glioma: a systematic review and meta-analysis of
individual patient data from 12 randomised trials. Lancet.
359:1011–1018. 2002.
|
|
4
|
Reardon DA, Rich JN, Friedman HS and
Bigner DD: Recent advances in the treatment of malignant
astrocytoma. J Clin Oncol. 24:1253–1265. 2006.
|
|
5
|
Stupp R, Dietrich P-Y, Kraljevic SO, et
al: Promising survival for patients with newly diagnosed
glioblastoma multiforme treated with concomitant radiation plus
temozolomide followed by adjuvant temozolomide. J Clin Oncol.
20:1375–1382. 2002.
|
|
6
|
Malumbres M and Barbacid M: Cell cycle,
CDKs and cancer: a changing paradigm. Nat Rev Cancer. 9:153–166.
2009.
|
|
7
|
Schwartz GK and Shah MA: Targeting the
cell cycle: a new approach to cancer therapy. J Clin Oncol.
23:9408–9421. 2005.
|
|
8
|
Deshpande A, Sicinski P and Hinds PW:
Cyclins and cdks in development and cancer: a perspective.
Oncogene. 24:2909–2915. 2005.
|
|
9
|
Harbour JW, Luo RX, Santi AD, Postigo AA
and Dean DC: Cdk phosphorylation triggers sequential intramolecular
interactions that progressively block Rb functions as cells move
through G1. Cell. 98:859–869. 1999.
|
|
10
|
Ezhevsky SA, Nagahara H, Vocero-Akbani AM,
Gius DR, Wei MC and Dowdy SF: Hypo-phosphorylation of the
retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results
in active pRb. Proc Natl Acad Sci USA. 94:10699–10704. 1997.
|
|
11
|
Hayette S, Tigaud I, Callet-Bauchu E, et
al: In B-cell chronic lymphocytic leukemias, 7q21 translocations
lead to overexpression of the CDK6 gene. Blood. 102:1549–1550.
2003.
|
|
12
|
Van Dross R, Yao S, Asad S, et al:
Constitutively active K-cyclin/cdk6 kinase in Kaposi
sarcoma-associated herpesvirus-infected cells. J Natl Cancer Inst.
97:656–666. 2005.
|
|
13
|
Lam PY, Di Tomaso E, Ng HK, Pang JC,
Roussel MF and Hjelm NM: Expression of p19INK4d, CDK4, CDK6 in
glioblastoma multiforme. Br J Neurosurg. 14:28–32. 2000.
|
|
14
|
Shi L, Zhang J, Pan T, et al: MiR-125b is
critical for the suppression of human U251 glioma stem cell
proliferation. Brain Res. 1312:120–126. 2010.
|
|
15
|
Li Y, Guessous F, Zhang Y, et al:
MicroRNA-34a inhibits glioblastoma growth by targeting multiple
oncogenes. Cancer Res. 69:7569–7576. 2009.
|
|
16
|
Mendrzyk F, Radlwimmer B, Joos S, et al:
Genomic and protein expression profiling identifies CDK6 as novel
independent prognostic marker in medulloblastoma. J Clin Oncol.
23:8853–8862. 2005.
|
|
17
|
Easton J, Wei T, Lahti JM and Kidd VJ:
Disruption of the cyclin D/cyclin-dependent
kinase/INK4/retinoblastoma protein regulatory pathway in human
neuroblastoma. Cancer Res. 58:2624–2632. 1998.
|
|
18
|
Bredel M and Zentner J: Brain-tumour drug
resistance: the bare essentials. Lancet Oncol. 3:397–406. 2002.
|
|
19
|
Feun LG, Savaraj N and Landy HJ: Drug
resistance in brain tumors. J Neurooncol. 20:165–176. 1994.
|
|
20
|
Bredel M: Anticancer drug resistance in
primary human brain tumors. Brain Res Rev. 35:161–204. 2001.
|
|
21
|
Declèves X, Fajac A, Lehmann-Che J, et al:
Molecular and functional MDR1-Pgp and MRPs expression in human
glioblastoma multiforme cell lines. Int J Cancer. 98:173–180.
2002.
|
|
22
|
Haga S, Hinoshita E, Ikezaki K, et al:
Involvement of the multidrug resistance protein 3 in drug
sensitivity and its expression inhuman glioma. Cancer Sci.
92:211–219. 2001.
|
|
23
|
de Murcia JM, Niedergang C, Trucco C, et
al: Requirement of poly(ADP-ribose) polymerase in recovery from DNA
damage in mice and in cells. Proc Natl Acad Sci USA. 94:7303–7307.
1997.
|
|
24
|
Cheng CL, Johnson SP, Keir ST, et al:
Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide
resistance in a DNA mismatch repair-deficient malignant glioma
xenograft. Mol Cancer Ther. 4:1364–1368. 2005.
|
|
25
|
Rhee CH, Hess K, Jabbur J, Ruiz M, Yang Y,
Chen S, Chenchik A, Fuller GN and Zhang W: cDNA expression array
reveals heterogeneous gene expression profiles in three
glioblastoma cell lines. Oncogene. 18:2711–2717. 1999.
|
|
26
|
Johnson DG, Schwarz JK, Cress WD and
Nevins JR: Expression of transcription factor E2F1 induces
quiescent cells to enter S phase. Nature. 365:349–352. 1993.
|
|
27
|
Chen H-Z, Tsai S-Y and Leone G: Emerging
roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev
Cancer. 9:785–797. 2009.
|
